Pharma Journalist -

Xspray Pharma AB has signed an agreement with EVERSANA to support the U.S. launch and commercialization of the company's first innovative cancer therapy Dasynoc for the treatment of…
Read More...

Sage Therapeutics, Inc. announced the European Medicines Agency (EMA) granted Orphan Drug Designation to SAGE-718 for the treatment of Huntington’s disease (HD). SAGE-718 is in…
Read More...

Moderna, Inc. and Life Edit Therapeutics Inc., an ElevateBio company announced a strategic research and development collaboration to discover and develop in vivo mRNA gene editing…
Read More...

GenScript ProBio and RVAC Medicines Pte. Ltd. announced an agreement to establish a strategic partnership for the manufacturing of GMP-grade plasmid DNA (pDNA) for its mRNA COVID-19…
Read More...

AstraZeneca’s tablet formulation of Calquence (acalabrutinib) has been approved in the European Union (EU) for the treatment of adult patients with chronic lymphocytic leukaemia (CLL).…
Read More...

Eterna Therapeutics Inc., a preclinical-stage biotechnology company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new…
Read More...

Beckley Psytech Ltd, a private, clinical-stage biotechnology company dedicated to addressing neuropsychiatric disorders by transforming psychedelics into safe, effective and licensed…
Read More...

Vaxcyte, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s infant Investigational New Drug (IND) application for VAX-24, its lead, 24-valent…
Read More...

Alnylam Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company’s supplemental New Drug Application (sNDA) for patisiran, an…
Read More...

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for its respiratory syncytial virus (RSV) vaccine…
Read More...